The CBSE conducted the Class 12 Physical Education (Code 048) exam smoothly across India, and students described the paper as ...
Halozyme Therapeutics is entering a powerful earnings inflection. FY25 revenue grew 38% to $1.397 billion. Check out why I am bullish on HALO stock.
Board-certified allergist and leading food allergy and anaphylaxis researcher joins Aquestive to support Anaphylm™ (dibutepinephrine) sublingual film NDA resubmission and pipeline WARREN, N.J., Feb.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results